Sage Journals: Discover world-class research

Retricted access

Research article

First published 2015-11

Are Phase 3 Clinical Trials Really Becoming More Complex?

Harold E. Glass, Jeffrey J. DiFrancesco, Lucas M. Glass [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2016-11

Pharmaceutical Organizational Size and Phase 3 Clinical Trial Completion Times

Harold E. Glass, Lucas M. Glass, Phuong Tran [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2019-5

Possible Causes of Failing to Meet Primary Endpoints: A Systematic Review of Randomized Controlled Phase 3 Clinical Trials in Patients With Non–Small Cell Lung Cancer

Mitsugu Ikeda, Tatsuya Ochibe, Masahiro Tohkin

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2015-2

A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designs

Cody Chiuzan, Elizabeth Garrett-Mayer, Sharon D Yeatts

Clinical Trials

Retricted access

Research article

First published 2016-2

Phase 3 Oncology Clinical Trials in South Africa

Tina Malan, Keymanthri Moodley

Journal of Empirical Research on Human Research Ethics

Open access

Research article

First published 2020-10

Clinical trial design in phase 2 and 3 trials for pulmonary hypertension

Sylvia Nikkho, Peter Fernandes, R. James White

Pulmonary Circulation

Retricted access

Research article

First published 1985-10

Organization and Development of Clinical Trial Protocols and Research Methodology in Geriatric Drug Testing: Phase 3 Studies (Dementia)

Richard A. Guarino

Therapeutic Innovation & Regulatory Science

Retricted access

Review article

First published 2020-9

Age demographics of subjects enrolled in interventional phase 3 multiple myeloma clinical trials

Abhilasha Borad, Hamnah Saeed, Michael Toscani [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2024-7

Race and ethnicity in multiple sclerosis phase 3 clinical trials: A systematic review

Marta Ponzano, Alessio Signori, Andrea Bellavia [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2007-7

Improving the Decision to Pursue a Phase 3 Clinical Trial by Adjusting for Patient-Specific Factors in Evaluating Phase 2 Treatment Efficacy Data

Glenn Heller, Michael W. Kattan, Howard I. Scher

Medical Decision Making

Search results